Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Julian P. T. Higgins

12 ta ish

University of Bristol

AkademScholarda batafsil koʻrsatkichlar

  1. RoB 2: a revised tool for assessing risk of bias in randomised trials

    Jonathan A C Sterne, Jelena Savović, Matthew J. Page +25

    BoshqaOchiq kirish201916 iqtibos
    ABI

  2. Measuring inconsistency in meta-analyses

    Julian P. T. Higgins, Simon G. Thompson, Jonathan J Deeks +1

    Sharh maqolaOchiq kirish200314 iqtibos
    ABI

  3. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

    Julian P. T. Higgins, Doug Altman, Peter C Gøtzsche +9

    MaqolaOchiq kirish20119 iqtibos
    ABI

  4. Quantifying heterogeneity in a meta‐analysis

    Julian P. T. Higgins, Simon G. Thompson

    Maqola20029 iqtibos
    ABI

  5. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

    Jonathan A C Sterne, Miguel A. Hernán, Barnaby C Reeves +32

    MaqolaOchiq kirish20167 iqtibos
    ABI

  6. Introduction to Meta‐Analysis

    Michael Borenstein, Larry V. Hedges, Julian P. T. Higgins +1

    Kitob20095 iqtibos
    ABI

  7. Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco

    Gareth J. Hollands, Ian Shemilt, Theresa M. Marteau +5

    Boshqa20143 iqtibos
    ABI

  8. The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis

    Emma L. Anderson, Laura D Howe, Hayley E Jones +3

    Sharh maqolaOchiq kirish20152 iqtibos
    ABI

  9. Interventions to prevent obesity in children aged 12 to 18 years old

    Francesca Spiga, E. Tomlinson, Annabel L. Davies +8

    Sharh maqolaOchiq kirish20242 iqtibos
    ABI

  10. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

    Jonathan A C Sterne, Alex J. Sutton, John P. A. Ioannidis +16

    MaqolaOchiq kirish20112 iqtibos
    ABI

  11. Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis

    Andrea Cipriani, Toshi A. Furukawa, Georgia Salanti +15

    Sharh maqola20182 iqtibos
    ABI

  12. Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane

    Ella Flemyng, Theresa HM Moore, Isabelle Boutron +4

    Sharh maqola20232 iqtibos
    ABI